Cycloleucine Encephalopathy, Rats and Mice

  • Henry C. Powell
Part of the Monographs on Pathology of Laboratory Animals book series (LABORATORY)


At postmortem examination decreased muscle mass and body fat and an empty gastrointestinal tract are evident.


Spongiform leukoencephalopathy spongiform encephalomyelopathy central myelinopathy 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aleu FP, Katzman R, Terry RD (1963) Fine structure and electrolyte analyses of cerebral edema induced by alkyltin intoxication. J Neuropathol Exp Neurol 22: 403–413CrossRefPubMedGoogle Scholar
  2. Aviado DM, Reutter HA (1969) Pathologic physiology and chemotherapy of Plasmodium berghei. IX. Gastric secretion and the influence of 1-amino cytopentane carboxylic acid (WR 14, 997 or cycloleucine). Exp Parasitol 26: 314–322CrossRefPubMedGoogle Scholar
  3. Berlinguet L, Begin N, Sarkar NK (1962) Mechanism of antitumour action of 1-amino-cyclopentane carboxylic acid. Nature 194:1082–1083CrossRefPubMedGoogle Scholar
  4. Caboche M, Bachellerie JP (1977) RNA methylation and control of eukaryotic RNA biosynthesis. Effects of cycloleucine, a specific inhibitor of methylation, on ribosomal RNA maturation. Eur J Biochem 74:19–29CrossRefPubMedGoogle Scholar
  5. Caboche M, Mulsant P (1978) Selection and preliminary characterization of cycloleucine-resistant CHO cells affected in methionine metabolism. Somatic Cell Genet 4: 407–421CrossRefPubMedGoogle Scholar
  6. Cammer W (1980) Toxic demyelination: biochemical studies and hypothetical mechanisms. In: Spencer PS, Schaumburg HH (eds) Experimental and clinical neurotoxicology. Williams and Wilkins, Baltimore, pp 239–256Google Scholar
  7. Carter SK (1970) 1-Aminocyclopentanecarboxylic acid (NSC-1026). A review. Chemotherapy fact sheet, July. National Cancer Institute, pp 1–9Google Scholar
  8. Chou SM, Waisman HA (1965) Spongy degeneration of the central nervous system: case of homocystinuria. Arch Pathol 79: 357–363PubMedGoogle Scholar
  9. Craan AG, Bregeron M (1978) Experimental cystinuria: the cycloleucine model. II. Amino acid efflux from intestinal and renal tissues. Metabolism 27: 1613–1625CrossRefPubMedGoogle Scholar
  10. Frish AW (1969) Inhibition of antibody synthesis by cycloleucine. Biochem Pharmacol 18: 256–260CrossRefGoogle Scholar
  11. Gandy G, Jacobson W, Sidman R (1973) Inhibition of a transmethylation reaction in the central nervous system-an experimental model for subacute combined degeneration of the cord. J Physiol (Lond) 233: 1P–3PPubMedGoogle Scholar
  12. Greco CM, Powell HC, Garrett RS, Lampert PW (1980) Cycloleucine encephalopathy. Neuropathol Appl Neurobiol 6: 349–360CrossRefPubMedGoogle Scholar
  13. Jacobson W, Gandy G, Sidman RL (1973) Experimental subacute combined degeneration of the cord in mice (abstr). J Pathol 109: PXIII–PXIVGoogle Scholar
  14. Lampert PW, Schochet SS (1968) Electron microscopic observations on experimental spongy degeneration of the cerebellar white matter. J Neuropathol Exp Neurol 27:210–220CrossRefPubMedGoogle Scholar
  15. Lampert P, O’Brien J, Garrett R (1973) Hexachlorophene encephalopathy. Acta Neuropathol (Berl) 23: 326–333CrossRefPubMedGoogle Scholar
  16. Levine S, Sowinski R (1977) Effects of cycloleucine on macrophages and on experimental allergic encephalomyelitis. Exp Mol Pathol 26: 103–112CrossRefPubMedGoogle Scholar
  17. Machlin LJ, Gordon RS, Puchal F (1963) Alleviation of 1-aminocyclopentane-l-carboxylic acid toxicity by valine. Nature 198: 87–88CrossRefGoogle Scholar
  18. Nixon RA (1976) Neurotoxicity of a non-metabolizable amino acid, aminocyclopentane-l-carboxylic acid: regional protein levels and lipid composition of nervous tissue. J Infect Dis 27: 237–244Google Scholar
  19. Nixon RA, Jacobson W, Sidman RL (1974) Methyltransferase activity in an experimental mouse disease resembling human subacute combined degeneration (abstr). J Neuropathol Exp Neurol 33:172Google Scholar
  20. Nixon RA, Suva M, Wolf MK (1976) Neurotoxicity of a nonmetabolizable amino acid, 1-aminocyclopentanel-carboxylic acid antagonism by amino acids in cultures of cerebellum. J Infect Dis 27: 245–251Google Scholar
  21. Owen G, Ruelius HW, Janssen F, Pollock JJ (1969) Species differences in the disposition of cycloleucine (abstr). Toxicol Appl Pharmacol 14: 630Google Scholar
  22. Pardridge WM, Oldendorf WH (1975) Kinetic analysis of blood-brain barrier transport of amino acids. Biochim Biophys Acta 401: 128–136CrossRefPubMedGoogle Scholar
  23. Powell HC, Lampert PW (1979) Hexachlorophene toxicity. In: Vinken PJ, Bruyn GW (eds) Intoxication of the nervous system. Part II. North Holland, Amsterdam, pp 479–509 (Handbook of clinical neurology, vol 37)Google Scholar
  24. Ramsey R, Fisher VW (1978) Effect of 1-aminocyclopentanel-carboxylic acid (cycloleucine) on developing rat central nervous system phospholipids. J Infect Dis 30: 447–457Google Scholar
  25. Rizzuto N, Gambetti PL (1976) Status spongiosus of rat central nervous system induced by antinomycin D. Acta Neuropathol (Berl) 36: 21–30CrossRefPubMedGoogle Scholar
  26. Ross RB, Noll CI, Ross WCJ et al. (1961) Cycloaliphatic amino acids in cancer chemotherapy. J Med Pharm Chem 3: 1–23CrossRefPubMedGoogle Scholar
  27. Scholefield PG (1961) Competition between amino acids for transport into Ehrlich ascites carcinoma cells. Can J Biochem 39:1717–1735CrossRefPubMedGoogle Scholar
  28. Siddons RC, Spence JA, Dayan AD (1975) Experimental models of vitamin B12 deficiency in the baboon. Adv Neurol 10: 239–252PubMedGoogle Scholar
  29. Spencer PS, Foster GV, Sterman AB, Horoupian D (1980) Acetyl ethyl tetramethyl tetralin. In: Spencer PS, Schaumburg HH (eds) Experimental and clinical neurotoxicology. Williams and Wilkins, Baltimore, pp 296–308Google Scholar
  30. Steinwall O, Snyder SH (1969) Brain uptake of C14 cycloleucine after damage to blood-brain barrier by mercuric ions. Acta Neurol Scand 45: 369–375CrossRefPubMedGoogle Scholar
  31. Sterling WR, Henderson JF (1963) Studies of the mechanism of action of 1-aminocyclopentane-l-carboxylic acid. Biochem Pharmacol 12: 303–316CrossRefPubMedGoogle Scholar
  32. Suzuk K, Kikkawa Y (1969) Status spongiosus of CNS and hepatic changes induced by cuprizone (biscyclohexanone oxalyldihydrazone). Am J Pathol 54: 307–325Google Scholar
  33. Yajima K, Suzuk K (1979) Ultrastructural changes of Oligodendroglia and myelin sheaths induced by ethidium bromide. Neuropathol Appl Neurobiol 5: 49–62CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • Henry C. Powell

There are no affiliations available

Personalised recommendations